迷幻药与精神分裂症：历史之谜

IF 2.2 Q3 PHARMACOLOGY & PHARMACY

Journal of Psychedelic Studies Pub Date : 2023-12-02 DOI:10.1556/2054.2023.00277

Mark Haden, B. Woods, Sarah A. Paschall

{"title":"迷幻药与精神分裂症：历史之谜","authors":"Mark Haden, B. Woods, Sarah A. Paschall","doi":"10.1556/2054.2023.00277","DOIUrl":null,"url":null,"abstract":"This analysis of current and historical research and clinical reports observes that the relationship between psychedelics and schizophrenia is complex and there are reports of psychedelics benefiting this population. Specifically, lower doses of psychedelics (mostly LSD) appear to have a potential beneficial impact on the negative symptoms of schizophrenia.","PeriodicalId":34732,"journal":{"name":"Journal of Psychedelic Studies","volume":"112 28","pages":""},"PeriodicalIF":2.2000,"publicationDate":"2023-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Psychedelics and schizophrenia: A mystery in history\",\"authors\":\"Mark Haden, B. Woods, Sarah A. Paschall\",\"doi\":\"10.1556/2054.2023.00277\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This analysis of current and historical research and clinical reports observes that the relationship between psychedelics and schizophrenia is complex and there are reports of psychedelics benefiting this population. Specifically, lower doses of psychedelics (mostly LSD) appear to have a potential beneficial impact on the negative symptoms of schizophrenia.\",\"PeriodicalId\":34732,\"journal\":{\"name\":\"Journal of Psychedelic Studies\",\"volume\":\"112 28\",\"pages\":\"\"},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2023-12-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Psychedelic Studies\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1556/2054.2023.00277\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Psychedelic Studies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1556/2054.2023.00277","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}

引用次数: 0

摘要

本文对当前和历史研究以及临床报告的分析表明，致幻剂和精神分裂症之间的关系是复杂的，并且有致幻剂对这一人群有益的报道。具体来说，低剂量的致幻剂(主要是LSD)似乎对精神分裂症的阴性症状有潜在的有益影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Psychedelics and schizophrenia: A mystery in history

This analysis of current and historical research and clinical reports observes that the relationship between psychedelics and schizophrenia is complex and there are reports of psychedelics benefiting this population. Specifically, lower doses of psychedelics (mostly LSD) appear to have a potential beneficial impact on the negative symptoms of schizophrenia.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of Psychedelic Studies Social Sciences-Anthropology

CiteScore

2.50

自引率

8.90%

发文量

审稿时长

26 weeks